Who Paid My Doc
RXLC 2118
Research payments
$1,651,026
Through program year 2024, $1,651,026 in research payments was reported against RXLC 2118, across 271 payments.
- Paid by (largest first)
- Sun Pharmaceutical Industries Inc.; Taro Pharmaceuticals USA, Inc.
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
2 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2024 | Research | $878,367 | 174 |
| 2023 | Research | $772,659 | 97 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Rebecca Soine New Orleans, LA Named on 25 payments
- Caroline Mbogua Houston, TX Named on 18 payments
- Janice Lima Maribona Miami, FL Named on 12 payments
- Aldo Maspons El Paso, TX Named on 12 payments
- Todd Dreitzler Scottsdale, AZ Named on 12 payments
- Sunil Dhawan Milpitas, CA Named on 11 payments
- Francisco Flores Hialeah, FL Named on 11 payments
- Nicole Seminara Cornelius, NC Named on 11 payments
- James Moretti Upper St. Clair, PA Named on 11 payments
- Igor Chaplik Miami, FL Named on 11 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.